Nathanael S Gray

USPTO Granted Patents = 16 (Patent Applications = 19)

CIPO Patents = 17 (Patent Applications = 101)

EPO Patents = 55 (Patent Applications = 162)

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 28(Granted Patents)

Company Filing History:

12 out of 1,210

Dana-farber-cancer Institute Inc.

patents

1 out of 5,469

The University of Texas System

patents

1 out of 444

The Broad Institute, Inc.

patents

4. 1 out of 2,893

The General Hospital Corporation

6. 4 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509455 - Imidazopyridine derivatives and aza-imidazopyridine derivatives as Janus kinase 2 inhibitors and uses thereof (2025-12-30),

2. 12497398 - Potent and selective covalent inhibitors of serine-arginine protein kinase (SRPK) 1 and SRPK2 and uses thereof (2025-12-16),

3. 12491251 - Degraders of cyclin-dependent kinase 7 (CDK7) and uses thereof (2025-12-09),

4. 12479847 - Pyrrolopyrimidine inhibitors of wild-type and mutant forms of LRRK2 (2025-11-25),

5. 12415816 - Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof (2025-09-16),

6. 12410194 - Potent and selective azaindole inhibitors of CDK8 and CDK19 (2025-09-09),

7. 12398145 - Bicyclic urea kinase inhibitors and uses thereof (2025-08-26),

8. 12391671 - Allosteric EGFR inhibitors and methods of use thereof (2025-08-19),

9. 12377080 - Allosteric EGFR inhibitors and methods of use thereof (2025-08-05),

10. 12365696 - Small-molecule focal adhesion kinase (FAK) inhibitors (2025-07-22),

11. 12365677 - Degraders that target proteins via KEAP1 (2025-07-22),

12. 12365664 - Small molecule inhibitors of SRC tyrosine kinase (2025-07-22),

13. 6803371 - Purine inhibitors of protein kinases, G proteins and polymerases (2004-10-12),

14. 6617331 - Purine inhibitors of protein kinases, G proteins and polymerases (2003-09-09),

15. 6573044 - Methods of using chemical libraries to search for new kinase inhibitors (2003-06-03),

Title: Inventor Nathanael S Gray: Pioneering Innovations in Berkeley

Introduction: Nathanael S. Gray is a renowned inventor based in Berkeley, CA, known for his groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Nathanael S. Gray holds several patents in the areas of cancer research, precision medicine, and targeted therapies, showcasing his commitment to advancing healthcare through innovation.

Career Highlights: With a distinguished career spanning over two decades, Nathanael S. Gray has held key research positions at leading academic institutions and biotech companies, where he has spearheaded numerous projects that have led to significant advancements in the medical field.

Collaborations: Throughout his career, Nathanael S. Gray has collaborated with top researchers, scientists, and pharmaceutical companies globally, fostering a culture of innovation and knowledge-sharing in the pursuit of developing cutting-edge treatments for complex diseases.

Conclusion: Inventor Nathanael S. Gray's relentless pursuit of innovation and his passion for improving patient outcomes have solidified his reputation as a trailblazer in the field of biotechnology, making him a key figure in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.